Heidi Kempinski
About Heidi Kempinski
Current Role at Aegle
Heidi Kempinski is the Chief Operational Officer at Aegle. She joined the company in 2020 as the Senior Vice President and Head of Operations. In her role, she oversees the strategic planning and implementation of operations across the company, ensuring that Aegle meets its goals in product development and program management.
Professional Experience and Expertise
Heidi Kempinski brings over 30 years of experience in global drug development to her role at Aegle. Her core areas of expertise include strategic planning, product development, program management, and business operations within R&D. Kempinski has held executive positions in multiple prominent pharmaceutical companies including GSK, TESARO, Abraxis BioScience, Eisai, MGI Pharma, Altus Pharmaceuticals, ZYCOS, and Transkaryotic Therapies.
Time at TESARO and Integration into GSK
As a founding team member at TESARO, Heidi Kempinski was instrumental in building out the company’s R&D operations and launching its initial products. Following the acquisition of TESARO by GSK, Kempinski served as the VP of Business Operations and Strategic Alliances. In this capacity, she led the successful integration of TESARO into GSK, managing global development, commercialization relationships, and strategic alliances.
Educational Background
Heidi Kempinski holds a Bachelor of Science degree in microbiology and chemistry from Quinnipiac University. She also earned an MBA with a focus on innovation and entrepreneurship from Northeastern University, providing her with a solid foundation in both scientific and business disciplines.